✦ LIBER ✦

Cyclophosphamide induced early-onset interstitial lung disease

✍ Scribed by Ozkok, Abdullah; Kaymaz, Sema; Elcioglu, Omer Celal; Bakan, Ali; Odabas, Ali Riza

Book ID: 118304445
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 166 KB
Volume: 1
Category: Article
ISSN: 2192-4449
DOI: 10.1007/s13730-012-0021-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P64 Early onset interstitial lung diseas

P64 Early onset interstitial lung disease and JO 1 positivity

✍ Praveen Kumar Yadav; C Jayakumar; Jacob Anthony 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Cyclophosphamide Responsive Interstitial

Cyclophosphamide Responsive Interstitial Lung Disease in “Overlap Syndrome”

✍ Elizabeth Schulman; Kun Chen; Gregory Saboeiro; Abraham Sanders; Kyriakos Kirou; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 289 KB

Interstitial lung disease and adult-onse

Interstitial lung disease and adult-onset still's disease

✍ R. J. Hoeyweghen; L. S. Clerck; J. F. Offel; W. J. Stevens 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 408 KB

Lenalidomide-Induced Interstitial Lung D

Lenalidomide-Induced Interstitial Lung Disease

✍ Yijia Chen; Porntip Kiatsimkul; Kenneth Nugent; Rishi Raj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

Oxaliplatin-induced interstitial lung di

Oxaliplatin-induced interstitial lung disease

✍ Francesco PICCOLO; Kynan T FEENEY; Anthony E TRIBE; Phil J THOMPSON; Michael J M 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

Rituximab-induced interstitial lung dise

Rituximab-induced interstitial lung disease

✍ Stephanie A. Wagner; Apurva C. Mehta; Damian A. Laber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract The aim of this study is to characterize rituximab‐induced interstitial lung disease (R‐ILD). The information on all reported cases of R‐ILD was reviewed. This analysis focused on patient characteristics, underlying disease, rituximab dosing schedule, and R‐ILD characteristic‐like sympt